CDTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.43%

Insider Buying (Last 12 Months): $57,700.00

Insider Selling (Last 12 Months): $58,005.00

Cidara Therapeutics Insider Trading History Chart

Cidara Therapeutics Share Price & Price History

^$13.00

▲ +0.71 (5.78%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Cidara Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2024	Leslie Tari	Insider	Sell	1,051	$13.40	$14,083.40	12,934
3/11/2024	Preetam Shah	CFO	Sell	946	$13.40	$12,676.40	11,360
3/11/2024	Shane Ward	COO	Sell	1,023	$13.40	$13,708.20	9,938
9/11/2023	Leslie Tari	Insider	Sell	923	$19.00	$17,537.00	13,785
8/14/2023	Leslie Tari	Insider	Buy	500	$19.40	$9,700.00	14,708
8/8/2023	Jeffrey Stein	CEO	Buy	2,500	$19.20	$48,000.00	16,580
3/27/2023	Jeffrey Stein	CEO	Buy	2,500	$20.80	$52,000.00	14,080
3/13/2023	Leslie Tari	Insider	Sell	378	$30.60	$11,566.80	9,508
3/13/2023	Preetam Shah	CFO	Sell	332	$30.60	$10,159.20	7,407
3/13/2023	Shane Ward	COO	Sell	216	$30.60	$6,609.60	4,228
1/12/2023	Leslie Tari	Insider	Sell	590	$24.00	$14,160.00	74
9/19/2022	Preetam Shah	CFO	Sell	782	$15.40	$12,042.80	7,539
9/12/2022	Paul Daruwala	COO	Sell	809	$13.60	$11,002.40	11,054
9/12/2022	Taylor Sandison	Insider	Sell	923	$13.60	$12,552.80	14,587
3/21/2022	Brady Johnson	VP	Sell	32	$16.20	$518.40
3/11/2022	Brady Johnson	VP	Sell	47	$14.20	$667.40
1/5/2022	Brady Johnson	VP	Sell	20	$25.00	$500.00
1/5/2022	Leslie Tari	Insider	Sell	62	$25.00	$1,550.00
1/5/2022	Paul Daruwala	COO	Sell	256	$25.00	$6,400.00
11/12/2021	Jeffrey Stein	CEO	Buy	2,500	$31.80	$79,500.00
11/12/2021	Preetam Shah	CFO	Buy	1,000	$30.80	$30,800.00
9/13/2021	Timothy R. Franson	Director	Buy	350	$42.40	$14,840.00
8/18/2021	Jeffrey Stein	CEO	Buy	2,000	$34.40	$68,800.00

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Cidara Therapeutics (NASDAQ:CDTX)

35.82% of Cidara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cidara Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2023	Pale Fire Capital SE	54,356	$51K	0.0%	N/A	0.060%
11/9/2023	Tocqueville Asset Management L.P.	98,000	$92K	0.0%	-13.3%	0.108%
10/24/2023	Raymond James Financial Services Advisors Inc.	79,119	$75K	0.0%	+25.2%	0.088%
10/17/2023	Flagship Harbor Advisors LLC	30,011	$28K	0.0%	N/A	0.033%
8/4/2023	Legacy Wealth Asset Management LLC	30,000	$34K	0.0%	N/A	0.033%
8/3/2023	Mackenzie Financial Corp	22,566	$26K	0.0%	N/A	0.025%
7/24/2023	Vontobel Holding Ltd.	82,185	$93K	0.0%	+55.5%	0.091%
7/18/2023	Stratos Wealth Partners LTD.	36,489	$41K	0.0%	+247.9%	0.041%
5/11/2023	Acadian Asset Management LLC	941,574	$1.19M	0.0%	-25.1%	1.046%
5/10/2023	Tocqueville Asset Management L.P.	167,000	$0.21M	0.0%	+22.8%	0.186%
5/9/2023	Callan Capital LLC	323,554	$0.41M	0.0%	+18.3%	0.359%
5/5/2023	Monashee Investment Management LLC	369,099	$0.47M	0.1%	N/A	0.410%
4/28/2023	Jeppson Wealth Management LLC	137,060	$0.17M	0.1%	-14.7%	0.191%
4/12/2023	Vontobel Holding Ltd.	52,841	$67K	0.0%	N/A	0.074%
2/15/2023	Nantahala Capital Management LLC	4,367,464	$3.30M	0.2%	-4.2%	6.098%
2/13/2023	Callan Capital LLC	273,554	$0.21M	0.0%	N/A	0.382%
2/9/2023	Tocqueville Asset Management L.P.	136,000	$0.10M	0.0%	+30.8%	0.190%
1/27/2023	Jeppson Wealth Management LLC	160,610	$0.12M	0.1%	-7.8%	0.224%
11/14/2022	Point72 Asset Management L.P.	3,868,006	$2.43M	0.0%	-7.9%	5.401%
11/10/2022	Nantahala Capital Management LLC	4,559,201	$2.92M	0.2%	-5.4%	6.366%
11/4/2022	Prudential Financial Inc.	54,000	$34K	0.0%	N/A	0.078%
11/1/2022	Monashee Investment Management LLC	369,099	$0.23M	0.1%	N/A	0.535%
8/15/2022	Nantahala Capital Management LLC	4,819,090	$2.36M	0.1%	-2.7%	6.979%
8/11/2022	Knott David M Jr	635,254	$0.31M	0.1%	+9.7%	0.920%
8/3/2022	Jeppson Wealth Management LLC	181,075	$88K	0.0%	+25.9%	0.262%
8/1/2022	US Bancorp DE	262,072	$0.13M	0.0%	N/A	0.380%
5/12/2022	Monashee Investment Management LLC	369,099	$0.31M	0.1%	N/A	0.535%
5/12/2022	Acadian Asset Management LLC	1,099,299	$0.91M	0.0%	+23.6%	1.592%
4/27/2022	Jeppson Wealth Management LLC	143,850	$0.12M	0.1%	+30.2%	0.211%
2/15/2022	Stonepine Capital Management LLC	2,311,530	$2.94M	1.3%	+195.3%	3.466%
2/15/2022	Laurion Capital Management LP	198,635	$0.25M	0.0%	N/A	0.298%
2/14/2022	Point72 Asset Management L.P.	4,200,000	$5.33M	0.0%	N/A	6.298%
2/10/2022	Acadian Asset Management LLC	889,469	$1.13M	0.0%	+51.6%	1.334%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	88,097	$0.11M	0.0%	+64.9%	0.132%
2/8/2022	Raymond James Financial Services Advisors Inc.	75,035	$95K	0.0%	-16.0%	0.113%
2/7/2022	West Family Investments Inc.	368,910	$0.47M	0.1%	N/A	0.553%
1/19/2022	Jeppson Wealth Management LLC	110,525	$0.14M	0.1%	+83.9%	0.166%
11/17/2021	Jeppson Wealth Management LLC	60,100	$0.13M	0.1%	+15.4%	0.121%
11/17/2021	Altium Capital Management LP	1,275,000	$2.02M	0.4%	N/A	2.569%
11/16/2021	Squarepoint Ops LLC	87,419	$0.20M	0.0%	-26.2%	0.177%
11/16/2021	Two Sigma Advisers LP	468,594	$1.05M	0.0%	+1,054.3%	0.947%
11/16/2021	Two Sigma Investments LP	373,338	$0.84M	0.0%	+571.5%	0.754%
11/16/2021	BVF Inc. IL	4,776,904	$10.70M	0.4%	+9.9%	9.649%
11/15/2021	Marshall Wace LLP	184,027	$0.41M	0.0%	N/A	0.372%
11/12/2021	Renaissance Technologies LLC	1,120,261	$2.51M	0.0%	+7.1%	2.263%
11/12/2021	Stonepine Capital Management LLC	782,817	$1.75M	0.8%	-35.4%	1.581%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	53,431	$0.12M	0.0%	N/A	0.108%
11/10/2021	Goldman Sachs Group Inc.	109,894	$0.25M	0.0%	-17.2%	0.222%
11/9/2021	BlackRock Inc.	332,066	$0.74M	0.0%	-10.3%	0.671%
11/9/2021	Monashee Investment Management LLC	369,099	$0.83M	0.2%	N/A	0.746%
10/19/2021	Kestra Advisory Services LLC	30,500	$68K	0.0%	N/A	0.062%
9/3/2021	Parametric Portfolio Associates LLC	34,001	$69K	0.0%	N/A	0.069%
8/17/2021	Millennium Management LLC	580,793	$1.17M	0.0%	+810.8%	1.203%
8/17/2021	Bridgeway Capital Management LLC	118,878	$0.24M	0.0%	-27.5%	0.246%
8/17/2021	BVF Inc. IL	4,346,904	$8.78M	0.3%	+16.2%	9.002%
8/16/2021	Squarepoint Ops LLC	118,482	$0.24M	0.0%	-36.7%	0.245%
8/16/2021	Opaleye Management Inc.	73,351	$0.15M	0.0%	N/A	0.152%
8/16/2021	Alethea Capital Management LLC	1,172,044	$2.37M	1.5%	+0.7%	2.427%
8/16/2021	Charles Schwab Investment Management Inc.	25,006	$51K	0.0%	-66.7%	0.052%
8/16/2021	State Street Corp	73,000	$0.15M	0.0%	-88.9%	0.151%
8/16/2021	Tibra Equities Europe Ltd	174,900	$0.35M	0.1%	N/A	0.362%
8/16/2021	Goldman Sachs Group Inc.	132,674	$0.27M	0.0%	-16.8%	0.275%
8/13/2021	Renaissance Technologies LLC	1,046,303	$2.11M	0.0%	+29.4%	2.167%
8/13/2021	Northern Trust Corp	72,428	$0.15M	0.0%	-80.7%	0.150%
8/13/2021	Geode Capital Management LLC	364,162	$0.74M	0.0%	-38.3%	0.754%
8/13/2021	Vanguard Group Inc.	1,986,440	$4.01M	0.0%	-7.2%	4.114%
8/12/2021	XTX Topco Ltd	25,971	$52K	0.0%	N/A	0.054%
8/12/2021	JPMorgan Chase & Co.	63,682	$0.13M	0.0%	-37.0%	0.132%
8/12/2021	Ergoteles LLC	163,000	$0.33M	0.0%	N/A	0.338%
5/21/2021	Citadel Advisors LLC	21,336	$57K	0.0%	N/A	0.044%
5/19/2021	Squarepoint Ops LLC	187,170	$0.50M	0.0%	+99.2%	0.388%
5/18/2021	Millennium Management LLC	63,770	$0.17M	0.0%	-68.0%	0.132%
5/18/2021	Citadel Advisors LLC	21,336	$57K	0.0%	N/A	0.044%
5/18/2021	California State Teachers Retirement System	57,902	$0.15M	0.0%	+11.9%	0.120%
5/17/2021	Ameriprise Financial Inc.	19,270	$51K	0.0%	N/A	0.040%
5/17/2021	Nuveen Asset Management LLC	197,517	$0.53M	0.0%	+46.0%	0.409%
5/17/2021	Goldman Sachs Group Inc.	159,459	$0.43M	0.0%	+225.4%	0.330%
5/14/2021	Public Employees Retirement System of Ohio	24,381	$65K	0.0%	+265.7%	0.050%
5/14/2021	Occudo Quantitative Strategies LP	26,142	$70K	0.0%	+45.7%	0.054%
5/14/2021	Alethea Capital Management LLC	1,163,631	$3.10M	1.9%	+0.8%	2.410%
5/13/2021	Barclays PLC	52,110	$0.14M	0.0%	+348.0%	0.108%
5/13/2021	Renaissance Technologies LLC	808,503	$2.15M	0.0%	-48.2%	1.674%
5/12/2021	Northern Trust Corp	374,406	$1M	0.0%	-4.0%	0.775%
5/12/2021	Geode Capital Management LLC	590,368	$1.57M	0.0%	+29.5%	1.223%
5/12/2021	JPMorgan Chase & Co.	101,057	$0.27M	0.0%	+5.8%	0.209%
5/11/2021	Acadian Asset Management LLC	289,654	$0.77M	0.0%	-13.2%	0.600%
5/11/2021	New York State Common Retirement Fund	35,802	$95K	0.0%	-50.0%	0.074%
5/10/2021	Russell Investments Group Ltd.	17,100	$45K	0.0%	N/A	0.035%
5/7/2021	BlackRock Inc.	1,833,051	$4.88M	0.0%	+3.1%	3.796%
3/5/2021	Jeppson Wealth Management LLC	52,252	$0.11M	0.1%	+63.5%	0.109%
2/19/2021	JPMorgan Chase & Co.	95,481	$0.19M	0.0%	+627.1%	0.217%
2/16/2021	Squarepoint Ops LLC	93,960	$0.19M	0.0%	+35.2%	0.214%
2/12/2021	Raymond James Financial Services Advisors Inc.	89,479	$0.18M	0.0%	-8.8%	0.204%
2/11/2021	Northern Trust Corp	390,018	$0.78M	0.0%	+1.3%	0.888%
2/10/2021	Rhumbline Advisers	32,338	$65K	0.0%	+37.2%	0.074%
2/10/2021	Renaissance Technologies LLC	1,559,654	$3.12M	0.0%	+24.3%	3.550%
2/9/2021	Wells Fargo & Company MN	75,279	$0.15M	0.0%	-20.0%	0.171%
2/9/2021	Bank of New York Mellon Corp	78,808	$0.16M	0.0%	-4.9%	0.179%
2/5/2021	BlackRock Inc.	1,777,812	$3.56M	0.0%	+4.4%	4.046%
2/4/2021	GSA Capital Partners LLP	179,515	$0.36M	0.1%	+594.7%	0.409%

Data available starting January 2016

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California.

Today's Range

Now: $13.00

$12.13

$14.96

50 Day Range

MA: $15.37

$10.25

$23.20

52 Week Range

Now: $13.00

$10.00

$29.60

Volume

751,351 shs

Average Volume

48,144 shs

Market Capitalization

$1.19 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98

Who are the company insiders with the largest holdings of Cidara Therapeutics?: Cidara Therapeutics' top insider investors include:
Jeffrey Stein (CEO)
Leslie Tari (Insider)
Taylor Sandison (Insider)
Preetam Shah (CFO)
Paul Daruwala (COO)
Shane Ward (COO)
Learn More about top insider investors at Cidara Therapeutics.